Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Amedisys Inc Lowers High End Of Prior FY 2013 Revenue Guidance; Lowers FY 2013 Earnings Guidance


Tuesday, 12 Nov 2013 08:00am EST 

Amedisys Inc announced that for fiscal 2013, it expects net service revenue to be in the range of $1.240 billion to $1.250 billion. Diluted earnings per share (EPS) to be in the range of $0.20 to $0.25 based on an estimated 31.7 million shares outstanding. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $1.277 billion and EPS of $0.55 for fiscal 2013. 

Company Quote

29.54
0.57 +1.97%
26 Dec 2014